Toll-like receptor 8 activation induces a neutrophil inflammatory phenotype: therapeutic implications for the utility of toll-like receptor 8 inhibition.
Saved in:
| Title: | Toll-like receptor 8 activation induces a neutrophil inflammatory phenotype: therapeutic implications for the utility of toll-like receptor 8 inhibition. |
|---|---|
| Authors: | Schmidt A; Merck Healthcare KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany., Coughlin M; EMD Serono Research & Development Institute, Inc., 45 Middlesex Turnpike, Billerica, MA 01821, USA, an affiliate of Merck KGaA., Catalina MD; EMD Serono Research & Development Institute, Inc., 45 Middlesex Turnpike, Billerica, MA 01821, USA, an affiliate of Merck KGaA., Przetak M; EMD Serono Research & Development Institute, Inc., 45 Middlesex Turnpike, Billerica, MA 01821, USA, an affiliate of Merck KGaA., Kalatskaya I; EMD Serono Research & Development Institute, Inc., 45 Middlesex Turnpike, Billerica, MA 01821, USA, an affiliate of Merck KGaA., Studham M; EMD Serono Research & Development Institute, Inc., 45 Middlesex Turnpike, Billerica, MA 01821, USA, an affiliate of Merck KGaA., Shaw J; EMD Serono Research & Development Institute, Inc., 45 Middlesex Turnpike, Billerica, MA 01821, USA, an affiliate of Merck KGaA., Bender AT; EMD Serono Research & Development Institute, Inc., 45 Middlesex Turnpike, Billerica, MA 01821, USA, an affiliate of Merck KGaA., Strand F; EMD Serono Research & Development Institute, Inc., 45 Middlesex Turnpike, Billerica, MA 01821, USA, an affiliate of Merck KGaA. |
| Source: | Journal of leukocyte biology [J Leukoc Biol] 2025 May 07; Vol. 117 (5). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8405628 Publication Model: Print Cited Medium: Internet ISSN: 1938-3673 (Electronic) Linking ISSN: 07415400 NLM ISO Abbreviation: J Leukoc Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
